FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial ; day:18 ; month:4 ; year:2022 ; pages:1-18
European journal of nuclear medicine and molecular imaging ; (18.4.2022), 1-18

Creator
Koster, Elizabeth J. de
Vriens, Dennis
Aken, Maarten O. van
Dijkhorst-Oei, Lioe-Ting
Oyen, Wim J. G.
Peeters, Robin P.
Schepers, Abbey
Geus-Oei, Lioe-Fee de
Hout, Wilbert B. van den
Contributor
SpringerLink (Online service)

DOI
10.1007/s00259-022-05794-w
URN
urn:nbn:de:101:1-2022070206542912379677
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Koster, Elizabeth J. de
  • Vriens, Dennis
  • Aken, Maarten O. van
  • Dijkhorst-Oei, Lioe-Ting
  • Oyen, Wim J. G.
  • Peeters, Robin P.
  • Schepers, Abbey
  • Geus-Oei, Lioe-Fee de
  • Hout, Wilbert B. van den
  • SpringerLink (Online service)

Other Objects (12)

Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules

Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules

[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial

[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules

Significance of indeterminate pulmonary nodules in resectable pancreatic adenocarcinoma—a review

Significance of indeterminate pulmonary nodules in resectable pancreatic adenocarcinoma—a review

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients

Diagnostic utility of RAS mutation testing for refining cytologically indeterminate thyroid nodules

Diagnostic utility of RAS mutation testing for refining cytologically indeterminate thyroid nodules

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules

Prediction of pulmonary metastasis in esophageal carcinoma patients with indeterminate pulmonary nodules

Prediction of pulmonary metastasis in esophageal carcinoma patients with indeterminate pulmonary nodules

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate

Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules

Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules

Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules

Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules

Related objects